Investor's Business Daily
Halozyme Therapeutics Stock Sees Relative Strength Rating
📈
AI Sentiment
Highly Positive
8/10
Halozyme Therapeutics Inc. News
Latest updates and market news for HALO
5 news
Dec 21 - Dec 27, 2025
Page 1
Simply Wall St.
Halozyme Therapeutics (HALO): Valuation Check After FDA Win and Patent Court Victory
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Halozyme Therapeutics (HALO) Is Up 7.4% After New ENHANZE NSCLC Win And Patent Injunction - What's Changed
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Is Halozyme Still Attractively Priced After Its Strong 2025 Share Price Rally?
📈
AI Sentiment
Highly Positive
9/10
Business Wire
Huonslab Announces Submission of Biologics License Application for Recombinant Human Hyaluronidase ‘HYDIZYME™’
📈
AI Sentiment
Highly Positive
8/10
Share this news page